Targeting chemokine-glycan interactions: the CellJammer® technology platform

Martin Trinker, Andreas J. Kungl

Research output: Contribution to journalArticleResearchpeer-review

Original languageEnglish
Pages (from-to)e253-e259
JournalDrug Discovery Today / Technologies
Volume9
Issue number4
Publication statusPublished - 2012

Fields of Expertise

  • Human- & Biotechnology

Treatment code (Nähere Zuordnung)

  • Review

Cite this